ABMD logo

Abiomed (ABMD) Shareholders Equity

Annual Shareholders Equity

$1.50 B
+$173.65 M+13.06%

31 March 2022

ABMD Shareholders Equity Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Shareholders Equity

$1.54 B
+$3.59 M+0.23%

30 September 2022

ABMD Quarterly Shareholders Equity Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ABMD Shareholders Equity Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year--
3 y3 years+13.1%+7.5%
5 y5 years+60.5%+47.1%

ABMD Shareholders Equity High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years
5 y5 years
alltimeall timeat highat high

Abiomed Shareholders Equity History

DateAnnualQuarterly
Sept 2022
-
$1.54 B(+0.2%)
June 2022
-
$1.54 B(+2.2%)
Mar 2022
$1.50 B(+13.1%)
$1.50 B(+4.9%)
Dec 2021
-
$1.43 B(+3.5%)
Sept 2021
-
$1.38 B(+5.9%)
June 2021
-
$1.31 B(-1.7%)
Mar 2021
$1.33 B(+24.8%)
$1.33 B(+5.4%)
Dec 2020
-
$1.26 B(+6.7%)
Sept 2020
-
$1.18 B(+7.3%)
June 2020
-
$1.10 B(+3.4%)
Mar 2020
$1.07 B(+13.7%)
$1.07 B(+1.8%)
Dec 2019
-
$1.05 B(+5.6%)
Sept 2019
-
$991.46 M(-1.1%)
June 2019
-
$1.00 B(+7.0%)
Mar 2019
$936.89 M(+35.9%)
$936.89 M(+10.0%)
Dec 2018
-
$851.53 M(+7.4%)
Sept 2018
-
$792.95 M(+9.6%)
June 2018
-
$723.36 M(+4.9%)
Mar 2018
$689.52 M(+52.5%)
$689.52 M(+9.0%)
Dec 2017
-
$632.48 M(+4.6%)
Sept 2017
-
$604.89 M(+6.7%)
June 2017
-
$567.04 M(+25.4%)
Mar 2017
$452.07 M(+22.6%)
$452.07 M(+8.3%)
Dec 2016
-
$417.38 M(+4.8%)
Sept 2016
-
$398.44 M(+5.6%)
June 2016
-
$377.33 M(+2.3%)
Mar 2016
$368.77 M(+26.5%)
$368.77 M(+6.7%)
Dec 2015
-
$345.53 M(+4.4%)
Sept 2015
-
$331.10 M(+7.5%)
June 2015
-
$308.05 M(+5.7%)
Mar 2015
$291.56 M(+73.2%)
$291.56 M(+49.0%)
Dec 2014
-
$195.72 M(+11.5%)
Sept 2014
-
$175.54 M(+3.0%)
June 2014
-
$170.35 M(+1.2%)
Mar 2014
$168.35 M(+22.8%)
$168.35 M(+4.9%)
Dec 2013
-
$160.46 M(+6.5%)
Sept 2013
-
$150.70 M(+6.7%)
June 2013
-
$141.31 M(+3.1%)
Mar 2013
$137.08 M(+8.5%)
$137.08 M(+0.8%)
Dec 2012
-
$136.04 M(-3.3%)
Sept 2012
-
$140.67 M(+7.8%)
June 2012
-
$130.52 M(+3.3%)
Mar 2012
$126.30 M(+20.6%)
$126.30 M(+7.2%)
Dec 2011
-
$117.78 M(+5.7%)
Sept 2011
-
$111.40 M(+0.2%)
June 2011
-
$111.18 M(+6.1%)
Mar 2011
$104.74 M(-3.0%)
$104.74 M(+3.5%)
Dec 2010
-
$101.18 M(-1.0%)
Sept 2010
-
$102.19 M(+3.5%)
June 2010
-
$98.76 M(-8.5%)
Mar 2010
$107.96 M(-6.9%)
$107.96 M(-2.0%)
Dec 2009
-
$110.16 M(-3.3%)
Sept 2009
-
$113.89 M(-2.5%)
June 2009
-
$116.75 M(+0.7%)
Mar 2009
$115.98 M(+23.9%)
$115.98 M(-8.2%)
Dec 2008
-
$126.34 M(-0.9%)
Sept 2008
-
$127.45 M(+35.5%)
June 2008
-
$94.07 M(+0.5%)
Mar 2008
$93.59 M(-23.3%)
$93.59 M(-10.0%)
Dec 2007
-
$104.00 M(-6.7%)
Sept 2007
-
$111.41 M(-5.3%)
June 2007
-
$117.62 M(-3.7%)
Mar 2007
$122.09 M
$122.09 M(+113.9%)
Dec 2006
-
$57.08 M(-6.4%)
Sept 2006
-
$60.98 M(-9.1%)
DateAnnualQuarterly
June 2006
-
$67.11 M(-3.4%)
Mar 2006
$69.49 M(+23.7%)
$69.49 M(-3.1%)
Dec 2005
-
$71.70 M(-6.2%)
Sept 2005
-
$76.44 M(-2.5%)
June 2005
-
$78.39 M(+39.5%)
Mar 2005
$56.18 M(+3.4%)
$56.18 M(+0.2%)
Dec 2004
-
$56.08 M(+1.6%)
Sept 2004
-
$55.21 M(+1.2%)
June 2004
-
$54.54 M(+0.4%)
Mar 2004
$54.34 M(-12.5%)
$54.34 M(-0.9%)
Dec 2003
-
$54.85 M(-2.9%)
Sept 2003
-
$56.48 M(-4.2%)
June 2003
-
$58.95 M(-5.1%)
Mar 2003
$62.09 M(-22.3%)
$62.09 M(-4.5%)
Dec 2002
-
$65.03 M(-6.4%)
Sept 2002
-
$69.47 M(-6.8%)
June 2002
-
$74.53 M(-6.7%)
Mar 2002
$79.87 M(-26.5%)
$79.87 M(-10.9%)
Dec 2001
-
$89.66 M(-6.6%)
Sept 2001
-
$96.04 M(-6.4%)
June 2001
-
$102.61 M(-5.6%)
Mar 2001
$108.68 M(-3.8%)
$108.68 M(-3.2%)
Dec 2000
-
$112.32 M(-3.3%)
Sept 2000
-
$116.12 M(+4.6%)
June 2000
-
$111.07 M(-1.6%)
Mar 2000
$112.92 M(+316.7%)
$112.92 M(+457.9%)
Dec 1999
-
$20.24 M(-13.3%)
Sept 1999
-
$23.33 M(-11.5%)
June 1999
-
$26.35 M(-2.8%)
Mar 1999
$27.10 M(-17.9%)
$27.10 M(-4.5%)
Dec 1998
-
$28.37 M(-7.4%)
Sept 1998
-
$30.64 M(-6.1%)
June 1998
-
$32.62 M(-1.1%)
Mar 1998
$33.00 M(+117.1%)
$33.00 M(-7.2%)
Dec 1997
-
$35.55 M(+8.9%)
Sept 1997
-
$32.65 M(+102.0%)
June 1997
-
$16.16 M(+6.3%)
Mar 1997
$15.20 M(+9.0%)
$15.20 M(+4.5%)
Dec 1996
-
$14.54 M(-2.1%)
Sept 1996
-
$14.85 M(+2.2%)
June 1996
-
$14.53 M(+4.2%)
Mar 1996
$13.94 M(+4.8%)
$13.94 M(+1.3%)
Dec 1995
-
$13.76 M(+1.5%)
Sept 1995
-
$13.55 M(+1.2%)
June 1995
-
$13.39 M(+0.7%)
Mar 1995
$13.30 M(+25.5%)
$13.30 M(+29.1%)
Dec 1994
-
$10.30 M(0.0%)
Sept 1994
-
$10.30 M(-1.0%)
June 1994
-
$10.40 M(-1.9%)
Mar 1994
$10.60 M(-15.2%)
$10.60 M(-3.6%)
Dec 1993
-
$11.00 M(-3.5%)
Sept 1993
-
$11.40 M(-2.6%)
June 1993
-
$11.70 M(-6.4%)
Mar 1993
$12.50 M(-23.3%)
$12.50 M(-5.3%)
Dec 1992
-
$13.20 M(-5.7%)
Sept 1992
-
$14.00 M(-7.9%)
June 1992
-
$15.20 M(-6.7%)
Mar 1992
$16.30 M(-23.1%)
$16.30 M(-7.9%)
Dec 1991
-
$17.70 M(-6.3%)
Sept 1991
-
$18.90 M(-6.4%)
June 1991
-
$20.20 M(-4.7%)
Mar 1991
$21.20 M(-19.7%)
$21.20 M(-19.7%)
Mar 1990
$26.40 M(+133.6%)
$26.40 M(+133.6%)
Mar 1989
$11.30 M(-16.3%)
$11.30 M(-16.3%)
Mar 1988
$13.50 M(+462.5%)
$13.50 M(+462.5%)
Mar 1987
$2.40 M
$2.40 M

FAQ

  • What is Abiomed annual stockholders equity?
  • What is the all time high annual shareholders equity for Abiomed?
  • What is Abiomed quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for Abiomed?

What is Abiomed annual stockholders equity?

The current annual shareholders equity of ABMD is $1.50 B

What is the all time high annual shareholders equity for Abiomed?

Abiomed all-time high annual stockholders equity is $1.50 B

What is Abiomed quarterly stockholders equity?

The current quarterly shareholders equity of ABMD is $1.54 B

What is the all time high quarterly shareholders equity for Abiomed?

Abiomed all-time high quarterly stockholders equity is $1.54 B